Cargando…

Optimal length of oral anticoagulant treatment for maximum benefit within 5 years after discontinuation of oral anticoagulants in patients with acute pulmonary embolism who require secondary thromboprophylaxis

BACKGROUND: Extended oral anticoagulant (OA) use is recommended in patients with acute pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the optimal length of OA use for the maximum long-term benefit in this patient population has been undefined to date. METHODS: A retr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yunfeng, Luo, Yong, Cheng, Yi, Wang, Hongwei, Du, He, Sun, Jinyuan, Xu, Mei, Xiong, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Pulmonary Vasculature
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441053/ https://www.ncbi.nlm.nih.gov/pubmed/37597971 http://dx.doi.org/10.1136/bmjresp-2023-001856

Ejemplares similares

Fever is associated with higher morbidity and clot burden in patients with acute pulmonary embolism
por: Saad, Muhammad, et al.
Publicado: (2018)

Safety and efficacy of catheter directed thrombolysis (CDT) in elderly with pulmonary embolism (PE)
por: Harrison, Eneida, et al.
Publicado: (2021)

Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study
por: Samaranayake, Chinthaka Bhagya, et al.
Publicado: (2023)

Signs and symptoms of acute pulmonary embolism and their predictive value for all-cause hospital death in respect of severity of the disease, age, sex and body mass index: retrospective analysis of the Regional PE Registry (REPER)
por: Ružičić, Dušan Predrag, et al.
Publicado: (2023)

Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy
por: Skoro-Sajer, Nika, et al.
Publicado: (2014)

Assessment of proximal pulmonary arterial stiffness using magnetic resonance imaging: effects of technique, age and exercise
por: Weir-McCall, Jonathan R, et al.
Publicado: (2016)

High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice
por: Schlosser, Kenny, et al.
Publicado: (2018)

Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study
por: Yorke, Janelle, et al.
Publicado: (2018)

Veterans Specific Activity Questionnaire (VSAQ): a new and efficient method of assessing exercise capacity in patients with pulmonary arteriovenous malformations
por: Gawecki, Filip, et al.
Publicado: (2019)

Combining creative writing and narrative analysis to deliver new insights into the impact of pulmonary hypertension
por: Goddard, Julia C, et al.
Publicado: (2017)

Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
por: Harbaum, Lars, et al.
Publicado: (2019)

Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
por: Dotan, Yaniv, et al.
Publicado: (2020)

Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance
por: Fartoukh, Muriel, et al.
Publicado: (2021)

Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
por: Heukels, Peter, et al.
Publicado: (2021)

Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study
por: Takita, Yuka, et al.
Publicado: (2021)

Incidence and outcomes of pulmonary hypertension in the Ireland
por: Cullivan, Sarah, et al.
Publicado: (2022)

Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension
por: Pi, Hongyang, et al.
Publicado: (2022)

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
por: Arora, Shreya, et al.
Publicado: (2021)

Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment
por: Al Yami, Majed S, et al.
Publicado: (2018)

New Oral Anticoagulants for Thromboprophylaxis after Elective Total Hip and Knee Arthroplasty
por: Friedman, Richard J.
Publicado: (2010)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Oral Anticoagulant Discontinuation and Its Predictors in Patients with Atrial Fibrillation
por: Kefale, Adane Teshome, et al.
Publicado: (2022)

ANTICOAGULATION AND COVID-19: A META-ANALYSIS
por: Ho, Kam Sing, et al.
Publicado: (2020)

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants
por: Baker, Christine L., et al.
Publicado: (2019)

Oral Anticoagulation Discontinuation Following Catheter Ablation of Typical Atrial Flutter
por: Alqam, Bilal M., et al.
Publicado: (2021)

THROMBUS IN TRANSIT: UNSUCCESSFUL ANTICOAGULATION IN A PATIENT WITH COVID-19
por: ALNABULSI, MOHAMMAD, et al.
Publicado: (2022)

The effect of new oral anticoagulants and extended thromboprophylaxis policy on hip and knee arthroplasty outcomes: observational study
por: Bottle, Alex, et al.
Publicado: (2015)

Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review
por: Buck, Jackie, et al.
Publicado: (2021)

Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2018)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
por: Mani, Helen, et al.
Publicado: (2015)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond
por: Dalager-Pedersen, Michael
Publicado: (2022)

Disposition of emergency department patients with acute pulmonary embolism after ambulance arrival
por: Rouleau, Samuel G., et al.
Publicado: (2023)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Systematic review on the effects of the discontinuation of the anticoagulant therapy and the postoperative bleeding, in patients under new oral anticoagulants after dental extraction
por: López-Galindo, Mónica, et al.
Publicado: (2023)

Successful secondary thromboprophylaxis with direct oral anticoagulants for a patient with catastrophic antiphospholipid syndrome: A case report
por: Dinh, Nhan Hieu, et al.
Publicado: (2020)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_77002dl7qfha9l41ticg5nb552